J.W. Cole Advisors, Inc. 9 Meters Biopharma, Inc. Transaction History

J.W. Cole Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	BUY	$0.21 - $0.32 $2,100 - $3,200	10,000 Added 18.18%	65,000 $14,000
Q1 2022 Jun 10, 2022	BUY	$0.52 - $1.0 $3,125 - $6,011	6,011 Added 12.27%	55,000 $33,000
Q1 2022 May 16, 2022	BUY	$0.52 - $1.0 $2,074 - $3,989	3,989 Added 8.86%	48,989 $39,000
Q4 2021 Jan 25, 2022	BUY	$0.85 - $1.33 $12,750 - $19,950	15,000 Added 50.0%	45,000 $44,000
Q3 2021 Oct 26, 2021	BUY	$1.03 - $1.41 $2,575 - $3,525	2,500 Added 9.09%	30,000 $39,000
Q1 2021 Apr 28, 2021	BUY	$0.84 - $2.16 $2,100 - $5,400	2,500 Added 10.0%	27,500 $32,000
Q4 2020 Feb 12, 2021	BUY	$0.65 - $1.11 $6,500 - $11,100	10,000 Added 66.67%	25,000 $21,000
Q3 2020 Nov 05, 2020	BUY	$0.48 - $0.84 $7,200 - $12,600	15,000 New	15,000 $12,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.